CELLECTAR BIOSCIENCES INC has a total of 47 patent applications. It decreased the IP activity by 77.0%. Its first patent ever was published in 2015. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are GUANGXI MEDICTOP PHARMACEUTICAL CO LTD, NANJING HAICHANG CHINESE MEDICINE GROUP CO LTD and TEFENG PHARMACEUTICAL CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | United States | 6 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Australia | 4 | |
#5 | Canada | 4 | |
#6 | China | 4 | |
#7 | Israel | 4 | |
#8 | Republic of Korea | 4 | |
#9 | Brazil | 3 | |
#10 | Singapore | 3 | |
#11 | Mexico | 2 | |
#12 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Special acyclic compounds | |
#4 | Electrotherapy | |
#5 | Analysing materials | |
#6 | Measuring electric variables |
# | Name | Total Patents |
---|---|---|
#1 | Pinchuk Anatoly | 21 |
#2 | Kozak Kevin | 20 |
#3 | Pak Chorom | 20 |
#4 | Longino Marc | 20 |
#5 | Longcor Jarrod | 18 |
#6 | Weichert Jamey P | 14 |
#7 | Stehle Nathan | 13 |
#8 | Titz Benjamin | 13 |
#9 | Grudzinski Joseph | 13 |
#10 | Weichert Jamey | 6 |
Publication | Filing date | Title |
---|---|---|
WO2021072300A1 | Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy | |
WO2021072235A1 | Fractionated dosing of a phospholipid ether analog for the treatment of cancer | |
WO2021050917A1 | Phospholipid ether conjugates as cancer-targeting drug vehicles | |
AU2019251483A1 | Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy | |
CA3096677A1 | Fractionated dosing of a phospholipid ether analog for the treatment of cancer | |
CN109791152A | For being identified and isolated from the phospholipid ether of circulating tumor cell like object | |
CN107708702A | Phospholipid ether is like pharmaceutical carrier of the thing as target on cancer |